Gastritis: The histology report

Digestive and Liver Disease

Volumn 43, Issue SUPPL. 4, 2011, Pages

  Rugge, Massimo ^a,b   Pennelli, Gianmaria ^a   Pilozzi, Emanuela ^c   Fassan, Matteo ^a   Ingravallo, Giuseppe ^d   Russo, Valentina M ^e   Di Mario, Francesco ^f  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF BARI   (Italy)

^e GARIBALDI HOSPITAL   (Italy)

^f UNIVERSITY OF PARMA   (Italy)

Author keywords

Atrophic gastritis; Gastritis; GIPAD report; Helicobacter pylori; OLGA staging

Indexed keywords

ARTICLE; ATROPHIC GASTRITIS; CLINICAL PRACTICE; COLUMNAR EPITHELIUM; DIAGNOSIS; ENDOCRINE CELL; EOSINOPHIL; FIBROSIS; GASTRITIS; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; HYPERPLASIA; INFLAMMATORY INFILTRATE; MONONUCLEAR CELL; MORPHOLOGICAL ADAPTATION; MORPHOLOGY; NEUTROPHIL; PRIORITY JOURNAL; SMOOTH MUSCLE; STOMACH DISEASE;

BIOPSY; GASTRIC MUCOSA; GASTRITIS; GASTRITIS, ATROPHIC; HELICOBACTER PYLORI; HUMANS; PATHOLOGY; RISK; SEVERITY OF ILLNESS INDEX; STOMACH NEOPLASMS;

EID: 79953225875     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(11)60593-8     Document Type: Article

References (44)

1. Pasechnikov VD, Chukov SZ, Kotelevets SM, et al. Invasive and non-invasive diagnosis of Helicobacter pylori-associated atrophic gastritis: a comparative study. Scand J Gastroenterol 2005, 40(3):297-301.
2. Rugge M Secondary prevention of gastric cancer. Gut 2007, 56(12):1646-1647.
3. Graham DY, Rugge M Clinical practice: diagnosis and evaluation of dyspepsia. J Clin Gastroenterol 2010, 44(3):167-172.
4. Dore MP, Graham DY Ulcers and gastritis. Endoscopy 2009, 42(1):38-41.
5. Lauwers GY, Fujita H, Nagata K, et al. Pathology of non-Helicobacter pylori gastritis: extending the histopathologic horizons. J Gastroenterol 2010, 45(2):131-145.
6. Filipe M, Munoz N, Matko I, et al. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer 1994, 57(3):324-329.
7. Sipponen P, Riihela M, Hyvärinen H, et al. Chronic nonatrophic (" superficial" ) gastritis increases the risk of gastric carcinoma. A case-control study. Scand J Gastroenterol 1994, 29(4):336-340.
8. Miehlke S, Hackelsberger A, Meining A, et al. Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori. Br J Cancer 1998, 78(2):263-266.
9. Cassaro M, Rugge M, Gutierrez O, et al. Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol 2000, 95(6):1431-1438.
10. Uemura N, Okamoto S, Yamamoto S Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001, 345(11):784-789.
11. Rugge M, Cassaro M, Di Mario F, et al. Interdisciplinary Group on Gastric Epithelial Dysplasia (IGGED): The long-term outcome of gastric non-invasive neoplasia. Gut 2003, 52(8):1111-1116.
12. Correa P The biological model of gastric carcinogenesis. IARC Sci Publ 2004, 157:301-310.
13. Stemmermann G Intestinal metaplasia of the stomach. A status report. Cancer 1994, 74(2):556-564.
14. Garcia S, Park HS, Novelli M, et al. Field cancerization, clonality, and epithelial stem cells: the spread of mutated clones in epithelial sheets. J Pathol 1999, 187(1):61-81.
15. Matsushima K, Isomoto H, Inoue N, et al. MicroRNA signatures in Helicobacter pylori-infected gastric mucosa. Int J Cancer 2010, [Epub ahead of print].
16. Vannella L, Lahner E, Osborn J, et al. Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis. Aliment Pharmacol Ther 2010, 31(9):1042-1050.
17. Niwa T, Tsukamoto T, Toyoda T, et al. Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. Cancer Res 2010, 70(4):1430-1440.
18. Correa P Chronic gastritis: a clinico-pathological classification. Am J Gastroenterol 1988, 83(5):504-509.
19. Price AB The Sydney System: histological division. J Gastroenterol Hepatol 1991, 6(3):209-222.
20. Whitehead R The classification of chronic gastritis: current status. J Clin Gastroenterol 1995, 21(Suppl 1):S131-S134.
21. Dixon M, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996, 20(10):1161-1181.
22. Genta RM Recognizing atrophy: another step toward a classification of gastritis. Am J Surg Pathol 1996, 20(Suppl 1):S23-S30.
23. Dixon M, Genta RM, Yardley JH, et al. Histological classification of gastritis and Helicobacter pylori infection: an agreement at last? The International Workshop on the Histopathology of Gastritis. Helicobacter 1997, 2(Suppl 1):S17-S24.
24. Meining A, Riedl B, Stolte M Features of gastritis predisposing to gastric adenoma and early gastric cancer. J Clin Pathol 2002, 55(10):770-773.
25. Rugge M, Genta RM Staging gastritis: an international proposal. Gastroenterology 2005, 129(5):1807-1808.
26. Rugge M, Genta RM Staging and grading of chronic gastritis. Hum Pathol 2005, 36(3):228-233.
27. Rugge M, Correa P, Di Mario F, et al. OLGA staging for gastritis: a tutorial. Dig Liver Dis 2008, 40(8):650-658.
28. Rugge M, Kim JG, Mahachai V, et al. OLGA gastritis staging in young adults and country-specific gastric cancer risk. Int J Surg Pathol 2008, 16(2):150-154.
29. Rugge M, de Boni M, Pennelli G, et al. OLGA can guard the barn. Am J Gastroenterol 2009, 104(12):3099. author reply 3101-2.
30. Rugge M, De Boni M, Pennelli G, et al. Gastritis OLGA-staging & gastric cancer risk: a twelve year clinico-pathological follow-up study. Aliment Pharmacol Ther 2010, 31(10):1104-1111.
31. Capelle LG, de Vries AC, Haringsma J, et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc 2010, 71(7):1150-1158.
32. Desmet V, Gerber M, Hoofnagle JH, et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994, 19(6):1513-1520.
33. UICC. TNM classification of malignant tumours. Seventh edition, 2009.
34. Sipponen P, Stolte M Clinical impact of routine biopsies of the gastric antrum and body. Endoscopy 1997, 29(7):671-678.
35. Rugge M, Cassaro M, Pennelli G, et al. Pathology and endoscopy in the reversibility assessment. Gut 2003, 52(3):1387-1388.
36. Guido M, Rugge M Liver biopsy sampling in chronic viral hepatitis. Semin Liver Dis 2004, 24(1):89-97.
37. Genta R Gastritis on the stage. Adv Anat Pathol 2007, 14(3):233.
38. Ruiz B, Garay J, Correa P, et al. Morphometric evaluation of gastric antral atrophy: improvement after cure of Helicobacter pylori infection. Am J Gastroenterol 2001, 96(12):3281-3287.
39. Rugge M, Correa P, Dixon MF, et al. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002, 16(7):1249-1259.
40. Rugge M, Meggio A, Pennelli G, et al. Gastritis staging in clinical practice: the OLGA staging system. Gut 2007, 56(5):631-636.
41. Gutiérrez-Gonzalez L, Wright NA Biology of intestinal metaplasia in 2008: more than a simple phenotypic alteration. Dig Liver Dis 2008, 40(7):510-522.
42. Weis VG, Goldenring JR Current understanding of SPEM and its standing in the preneoplastic process. Gastric Cancer 2009, 12(4):189-197.
43. Nam KT, Lee HJ, Sousa JF, et al. Mature chief cells are cryptic progenitors for metaplasia in the stomach. Gastroenterology 2010, 139(6):2028-2037.
44. Rindi G, Bordi C, La Rosa S, et al. Gastroenteropancreatic (neuro) endocrine neoplasms: The histology report. Dig Liver Dis 2011, 43(Suppl 4):S356-S360.